Oral Administration of Ulva pertusa Kjellman Improves Intestinal Motility Against Loperamide-Induced Constipation in Mice
Source abstract
Abstract
Ulva pertusa Kjellman (U. pertusa) is a seaweed indigenous to the intertidal zone of the Korean coastline. U. pertusa exhibits immune-enhancing and antitumor activities, and its effects on intestinal health have gained attention. However, the mechanisms underlying its beneficial effects on intestinal physiology remain elusive. Here, the effect of U. pertusa intake in ameliorating loperamide-induced constipation in male mice was evaluated. Additionally, cellular levels of proinflammatory cytokines, including nuclear factor-kB and interleukin-1β, were assessed to decipher the intricate interplay between inflammation and improvements in bowel movement. U. pertusa intake increased fecal weight and water content and improved the intestinal transit rate. Moreover, it reduced the levels of proinflammatory cytokines, possibly via short-chain fatty acids implicated in modulating intestinal motility and mucosal inflammation. These findings underscore the efficacy of U. pertusa in improving bowel motility and intestinal functionality, and its potential in ameliorating constipation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Seaweed-derived Bioactive Compounds · Therapeutic Uses of Natural Elements · Endometriosis Research and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jeju Bio Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju 63349, Republic of Korea
Department of Marine Technology & Convergence Engineering (Marine Biotechnology), KIOST School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
Funding
Korea Institute of Marine Science & Technology Promotion (KIMST) · Ministry of Oceans and Fisheries · Korea Institute of Ocean Science and Technology
References (36)
Show source-provided references
1. Chronic constipation: A review of literature10.1097/MD.0000000000010631 ↗
2. Chronic constipation: New insights, better outcomes?10.1016/S2468-1253(19)30199-2 ↗
3. Systematic review: Impact of constipation on quality of life in adults and children10.1111/j.1365-2036.2010.04273.x ↗
4. The burden of constipation on quality of life: Results of a multinational survey10.1111/j.1365-2036.2007.03376.x ↗
5. Diagnosis and treatment of chronic constipation—A European perspective10.1111/j.1365-2982.2011.01709.x ↗
6. Fermented milk containing Lactobacillus casei Zhang and Bifidobacterium animalis ssp. lactis V9 alleviated constipation symptoms through regulation of intestinal microbiota, inflammation, and metabolic pathways10.3168/jds.2020-18639 ↗
7. Yang, L., Wang, Y., Zhang, Y., Li, W., Jiang, S., Qian, D., and Duan, J. (2022). Gut microbiota: A new avenue to reveal pathological mechanisms of constipation. Appl. Microbiol. Biotechnol., 106.10.1007/s00253-022-12197-2 ↗
8. Zhao, Q., Chen, Y.-Y., Xu, D.-Q., Yue, S.-J., Fu, R.-J., Yang, J., Xing, L.-M., and Tang, Y.-P. (2021). Action mode of gut motility, fluid and electrolyte transport in chronic constipation. Front. Pharmacol., 12.10.3389/fphar.2021.630249 ↗
9. Loperamide: A pharmacological review
10. Katzung, B.G. (2004). Basic and Clinical Pharmacology, McGraw-Hill Publishing Co.. [9th ed.].
11. The role of loperamide in gastrointestinal disorders
12. Abuse potential of loperamide10.1038/clpt.1980.239 ↗
13. Mechanisms of antidiarrhoeal activity of methanol leaf extract of Combretum hypopilinum diels (combretaceae): Involvement of opioidergic and (α1 and β)-adrenergic pathways10.1016/j.jep.2020.113750 ↗
14. Metabolomics approach to serum biomarker for loperamide-induced constipation in SD rats10.5625/lar.2014.30.1.35 ↗
15. Protective effects of curcumin against rat intestinal inflammation-related motility disorders10.3892/mmr.2021.12030 ↗
16. Purgative/laxative actions of Globularia alypum aqueous extract on gastrointestinal-physiological function and against loperamide-induced constipation coupled to oxidative stress and inflammation in rats10.1111/nmo.13858 ↗
17. Seasonal variation of antibacterial activities in the green alga Ulva pertusa Kjellman
18. In vitro antioxidant activity of acetylated derivatives of polysaccharide extracted from Ulva pertusa (Cholorophta)10.5897/JMPR10.019 ↗
19. Antioxidant and immunomodulatory effects of Ulva pertusa Kjellman on broiler chickens10.5187/JAST.2011.53.5.419 ↗
20. A role for dietary macroalgae in the amelioration of certain risk factors associated with cardiovascular disease10.2216/15-77.1 ↗
21. Bioethanol production from seaweed Ulva pertusa for environmental application10.7841/ksbbj.2011.26.4.317 ↗
22. Kang, J.H., Jang, J.E., Kim, J.H., Byeon, S.Y., Kim, S., Choi, S.K., Kang, Y.H., Park, S.R., and Lee, H.J. (2019). Species Composition, Diversity, and Distribution of the Genus Ulva along the Coast of Jeju Island, Korea Based on Molecular Phylogenetic Analysis. PLoS ONE, 14.10.1371/journal.pone.0219958 ↗
23. Study on marine pectin extraction and its antioxidant activities from 14 marine algae under different extraction solvents10.3746/jkfn.2020.49.7.677 ↗
24. Horwitz, W., and Latimer, G. (2000). Official Methods of Analysis of AOAC International, Association of Analytical Chemists International. [17th ed.].
25. Koh, E.J., Shin, K.S., Sunwoo, I.Y., Kim, J., and Choi, W.Y. (2024). Brown seaweed byproduct extracts improve intestinal motility and auto-inflammation in mice with loperamide-induced constipation. Foods, 13.10.3390/foods13132037 ↗
26. Sources of Pectin, Extraction and its Applications in Pharmaceutical Industry—An Overview
27. Characterization of a novel sulfated-rhamnoglucuronan isolated from Korean seaweed Ulva pertusa and its efficacy for treatment of inflammatory bowel disease in mice10.1016/j.carbpol.2024.122373 ↗
28. Loperamide toxicity: Recommendations for patient monitoring and management10.1080/15563650.2019.1681443 ↗
29. Liu, B., Zhang, Z., Liu, X., Hu, W., and Wu, W. (2023). Gastrointestinal Fermentable Polysaccharide Is Beneficial in Alleviating Loperamide-Induced Constipation in Mice. Nutrients, 15.10.3390/nu15204364 ↗
30. Modulation of gut microbiota and intestinal metabolites by lactulose improves loperamide-induced constipation in mice10.1016/j.ejps.2020.105676 ↗
31. Markowiak-Kopeć, P., and Śliżewska, K. (2020). The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients, 12.10.3390/nu12041107 ↗
32. Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., and Amedei, A. (2019). Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease. Front. Immunol., 10.10.3389/fimmu.2019.02754 ↗
33. Kaminsky, L.W., Al-Sadi, R., and Ma, T.Y. (2021). IL-1β and the intestinal epithelial tight junction barrier. Front. Immunol., 12.10.3389/fimmu.2021.767456 ↗
34. Butyrate inhibits inflammatory responses through NFkappa B inhibition: Implications for Crohn’s disease10.1136/gut.47.3.397 ↗
35. The association between modulating inflammatory cytokines and constipation of geriatrics in Iran10.15171/mejdd.2017.78 ↗
36. Ferreira, A.C.F.M., Eveloff, R.J., Freire, M., and Santos, M.T.B.R. (2021). The impact of oral-gut inflammation in cerebral palsy. Front. Immunol., 12.10.3389/fimmu.2021.619262 ↗